23 Hrs
Source:
فيتو
Most Read
_1777352142843_145525226.png&w=48&q=75){kind=small}
Source: فيتو
23 Hrsفيتو
Source: فيتو
23 HrsReady to play
Ready to play
A recent study has shown that GLP-1 medications, used to treat obesity and type 2 diabetes, may reduce the risk of breast cancer by up to 30%. The findings, presented at the 2026 Annual Meeting of the American Society of Clinical Oncology and published in the journal JCO Oncology Practice, confirm that the use of these drugs is associated with a decreased likelihood of developing cancer.
Notice: This Is an AI-Generated Summary
Comments (0)